HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Clinical trials for HEPATOCELLULAR CARCINOMA BY BCLC STAGE explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA BY BCLC STAGE trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA BY BCLC STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancer patients with damaged livers?
Disease control CompletedThis study tested a drug called tislelizumab in 50 people with advanced liver cancer who also have moderate liver damage (Child-Pugh B). The goal was to see if the drug could shrink tumors. Tislelizumab works by helping the immune system attack cancer cells. The study took place …
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Brazilian liver cancer study reveals Real-World treatment patterns
Knowledge-focused CompletedThis study reviewed medical records of 300 liver cancer patients in Brazil to understand their health, treatments, and survival. It did not test any new drugs or treatments. The goal was to learn more about how liver cancer is managed in real-world settings.
Matched conditions: HEPATOCELLULAR CARCINOMA BY BCLC STAGE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC